# Aucta Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aucta-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Shanghai, China
- Website: www.auctapharma.com
- Latest round: Angel (Jan 26, 2016)
- Investors on record: 4

## About

Based in Shanghai, China and founded in 2012, Aucta Pharmaceuticals, Inc. is a developer focusing on the research and development of generic drugs and new dosage forms. The company's founder Dr. Li has 20 years of pharmaceutical industry experience, he is responsible for the overall strategy, direction, and growth of the business. He once served as manager in Novartis Pharmaceuticals and Eon Labs.

The company is creating new therapeutics, including new dosage forms, new dosing regimens and new indications. The company is developing products in CNS, in particular, epilepsy, Dermatology and Pediatrics. There are 3 programs undergoing Ph2/Ph3 clinical trials, one of which is an orphan drug product, two of which are innovative in nature. The company also has more than 10 pipeline products at various stages of development.

## Funding rounds

- Angel, Jan 26, 2016 — Fang Fund Partners, Grand Yangtze Capital, Co-Win Ventures, Sangel Capital

## Investors

- Fang Fund Partners (https://capitalatlas.ai/funds/fang-fund-partners) — Angel
- Grand Yangtze Capital (https://capitalatlas.ai/funds/grand-yangtze-capital) — Angel
- Co-Win Ventures (https://capitalatlas.ai/funds/co-win-ventures) — Angel
- Sangel Capital (https://capitalatlas.ai/funds/sangel-capital) — Angel